Project & portfolio management in the pharmaceutical industry

4th March 2013

Fleming Europe discussing new PPM strategies in Frankfurt
Due to high uncertainty of success and destinations of substantial investments, pharmaceutical development projects tend to be many years in duration. According to this situation and existing challenges such as the effective management of drug development portfolios, the impact of rising R&D costs and falling productivity levels, pharma companies have started paying greater attention to their portfolio strategies, resource allocation and decision making processes.

  • Is innovation and partnering the key solution to a successful product and technology portfolio?
  • Does the emerging market gold rush present a new era for pharma companies?
  • What is the new role of “innovation agents” in current challenging times?
  • Are you aware of the importance of innovative science in today's ambitious environment?

Ready to answer all the questions, Fleming Europe has organised its 8th Annual conference:
15 – 16 November, Frankfurt, Germany
Pharmaceutical experts from the Big pharma companies such as Pfizer, Novartis, AstraZeneca, Merck Serono, Actelion, Bayer, Lundbeck, UCB, Novartis and others are coming to Frankfurt to discuss recent challenges, share their knowledge and best practices.
In order to keep you up to date with all the recent developments we have chosen some of the hottest topics including innovation & partnering, portfolio risk analyses, project prioritization, emerging markets and many more.
Join us at this event to benefit from industry experts' practical solutions and get a unique opportunity to benchmark PPM practices with leading pharma companies.
Fleming Europe's 8th annual event is aimed at CxOs, SVPs, VPs, Global Heads, Heads, Senior Directors, Directors, Senior Managers, Managers, Team Leaders, Researchers, Scientists of Pharma/Biotech companies responsible for Portfolio Management, Project Management, Lifecycle Management, Risk Management, Pharmaceutical Development, R&D, Portfolio Strategy, Strategic Planning, Portfolio Analysis, Portfolio Selection, Decision Analysis, Business Development.
If you want to be up-to-date with the latest developments in PPM strategies, subscribe to our Pharma R&D and Clinical Trials Forum.





To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited